Related Experiment Video
Updated: Jun 6, 2025
04:25
Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
Published on: October 28, 2021
9.0K
Brain Metastasis in Pediatric Patients with Osteosarcoma
Jacob Murphy1, R Taylor Sundby2, Erin E Resch3
1Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
Current Oncology (Toronto, Ont.)
|November 26, 2024
Summary
Brain metastases in pediatric osteosarcoma are rare but deadly. Multimodal treatments, including novel drug combinations, may offer survival benefits, but further research is crucial for improved outcomes.
Area of Science:
- Pediatric Oncology
- Cancer Metastasis
- Neurological Oncology
Background:
- Brain metastases are infrequent in pediatric osteosarcoma.
- Their occurrence is linked to a poor prognosis.
Purpose of the Study:
- To review pediatric osteosarcoma patients with brain metastases.
- To analyze treatment outcomes and identify potential therapeutic strategies.
Main Methods:
- Retrospective analysis of six pediatric patients with osteosarcoma brain metastases.
- Review of treatments including chemotherapy, surgery, and radiation therapy.
Main Results:
- Median survival post-brain metastasis was 2.5 months.
- Most patients had fatal outcomes despite aggressive treatment.
- One patient showed prolonged survival (13+ months) with multimodal therapy including cabozantinib and nivolumab, suggesting potential immune microenvironment changes.
Conclusions:
- Vigilant monitoring for neurological symptoms is essential.
- Diagnostic challenges and rapid progression necessitate further research.
- Prospective studies and clinical trials for novel therapies are critical to improve outcomes.
